Solstice Advanced Materials

SOLSNASDAQUSD

THESIS ALERT

Email me when the SOLS thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$67.15
+$2.13 (+3.28%)Today 1M +9.45%
After hours$67.150.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

—
Source valuation snapshot. Not a live recalculation.
—
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
—
Diluted earnings per share from the latest filed annual.
$65.02
Prior regular-session close from the quote source.
$65.68–$67.76
Regular-session low and high so far today.
2.0M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 10 projected
Projected for 2027-02-10 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$40.43–$90.80
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own SOLS if those regulatory tailwinds and its large‑scale investments translate into restored margins and cash after the 2025 balance‑sheet shock.

SOLS price history

Latest price$67.15Today+$2.13 (+3.28%)
SOLS +9.75%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

INVESTMENT THESIS

What must happen next

5 MATERIAL PROPOSITIONS
  • Regulatory transitions to next‑generation, low‑GWP refrigerants will keep core product demand stable-to-growing and allow Solstice to maintain pricing power, because customers must buy compliant chemistries from qualified suppliers.HoldingMateriality: High

    Revenue increased from 3,649,000,000 (2023) to 3,886,000,000 (2025), showing continued baseline demand. If true, revenue and pricing power will be durable and investment in capacity will pay off; if false, volumes and prices could fall and leave new capacity underutilized.

    Watch: Regulators choose or accelerate policies that favor non‑fluorinated alternatives (making current chemistries less relevant).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Revenue increased from 3,649,000,000 (2023) to 3,886,000,000 (2025), showing continued baseline demand.

    Open source ↗
  • The AES facility expansion and other large scale manufacturing investments (including DOE cost‑sharing) create a capital‑intensive barrier to entry that secures long‑term volumes for Solstice and supports margins if the facility ramps successfully.StrengtheningMateriality: High

    Total assets rose from 5,004,000,000 (2024) to 5,673,000,000 (2025), consistent with large capital investments. If capacity comes online and is cost‑competitive, Solstice should capture incremental demand and defend pricing; if it is delayed or overbudget, the company may carry underutilized assets and higher costs.

    Watch: Construction delays, major cost overruns, or DOE funding withdrawal that delay commercial production.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Total assets rose from 5,004,000,000 (2024) to 5,673,000,000 (2025), consistent with large capital investments.

    Open source ↗
  • Raw material price volatility, scarcity and supplier constraints will show up as pressure on operating cash flow and margins unless Solstice can pass costs to customers or hedge inputs effectively.StrengtheningMateriality: Medium

    Operating cash flow declined from 842,000,000 (2024) to 455,000,000 (2025), indicating stress in cash conversion. Operating cash flow and margin resilience determines free cash flow available for deleveraging, dividends or buybacks; persistent cash pressure forces dilution or deferral of strategic investments.

    Watch: Inability to pass rising input costs through contracts or the market because customers push back or competitors absorb costs.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating cash flow declined from 842,000,000 (2024) to 455,000,000 (2025), indicating stress in cash conversion.

    Open source ↗
  • The large increase in liabilities in 2025 materially raises financing risk and could constrain operations or force equity dilution if not resolved or refinanced.StrengtheningMateriality: Medium

    Liabilities increased from 1,822,000,000 (2024) to 4,296,000,000 (2025), a large balance‑sheet change. A deteriorated balance sheet limits flexibility to complete AES ramp, invest in R&D, or ride through cyclical stress; resolving it is necessary for the valuation to be sustained.

    Watch: A multi‑year legal or environmental liability, regulatory fine, or settlement that requires large cash outflows.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Liabilities increased from 1,822,000,000 (2024) to 4,296,000,000 (2025), a large balance‑sheet change.

    Open source ↗
  • The stock price is pricing a recovery of EPS and operating cash flow toward earlier levels; investors require visible evidence of margin and EPS normalization for the multiple to be justified.HoldingMateriality: Medium

    Diluted EPS fell from 3.91 (2023) to 3.74 (2024) to 1.49 (2025), showing the earnings hit that must be reversed. If EPS and cash do not recover, the current high multiple will compress; conversely, a demonstrable recovery would validate the valuation and allow upside.

    Watch: Sustained lower margins and EPS from recurring higher input costs, structural pricing pressure, or permanent demand decline.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Diluted EPS fell from 3.91 (2023) to 3.74 (2024) to 1.49 (2025), showing the earnings hit that must be reversed.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Regulatory transitions to next‑generation, low‑GWP refrigerants will keep core product demand stable-to-growing and allow Solstice to maintain pricing power, because customers must buy compliant chemistries from qualified suppliers. If true, revenue and pricing power will be durable and investment in capacity will pay off; if false, volumes and prices could fall and leave new capacity underutilized.

The AES facility expansion and other large scale manufacturing investments (including DOE cost‑sharing) create a capital‑intensive barrier to entry that secures long‑term volumes for Solstice and supports margins if the facility ramps successfully. If capacity comes online and is cost‑competitive, Solstice should capture incremental demand and defend pricing; if it is delayed or overbudget, the company may carry underutilized assets and higher costs.

Raw material price volatility, scarcity and supplier constraints will show up as pressure on operating cash flow and margins unless Solstice can pass costs to customers or hedge inputs effectively. Operating cash flow and margin resilience determines free cash flow available for deleveraging, dividends or buybacks; persistent cash pressure forces dilution or deferral of strategic investments.

The large increase in liabilities in 2025 materially raises financing risk and could constrain operations or force equity dilution if not resolved or refinanced. A deteriorated balance sheet limits flexibility to complete AES ramp, invest in R&D, or ride through cyclical stress; resolving it is necessary for the valuation to be sustained.

The stock price is pricing a recovery of EPS and operating cash flow toward earlier levels; investors require visible evidence of margin and EPS normalization for the multiple to be justified. If EPS and cash do not recover, the current high multiple will compress; conversely, a demonstrable recovery would validate the valuation and allow upside.

All standing thesis claims
Original report summary

those regulatory tailwinds and its large‑scale investments translate into restored margins and cash after the 2025 balance‑sheet shock.

Evidence assessed Nov 10, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Solstice Advanced Materials

Where the evidence on Solstice Advanced Materials stands: Holding on the latest evidence (Nov 10, 2026). Of its 5 thesis points, 3 strengthening and 2 holding.

Bull case: what the evidence supports

  • Regulatory transitions to next‑generation, low‑GWP refrigerants will keep core product demand stable-to-growing and allow Solstice to maintain pricing power, because customers must buy compliant chemistries from qualified suppliers.

    sec.gov ↗

  • The AES facility expansion and other large scale manufacturing investments (including DOE cost‑sharing) create a capital‑intensive barrier to entry that secures long‑term volumes for Solstice and supports margins if the facility ramps successfully.

    sec.gov ↗

  • Raw material price volatility, scarcity and supplier constraints will show up as pressure on operating cash flow and margins unless Solstice can pass costs to customers or hedge inputs effectively.

    sec.gov ↗

  • The large increase in liabilities in 2025 materially raises financing risk and could constrain operations or force equity dilution if not resolved or refinanced.

    sec.gov ↗

  • The stock price is pricing a recovery of EPS and operating cash flow toward earlier levels; investors require visible evidence of margin and EPS normalization for the multiple to be justified.

    sec.gov ↗

Bear case: what would count against it

  • Regulators choose or accelerate policies that favor non‑fluorinated alternatives (making current chemistries less relevant).

    sec.gov ↗

  • Construction delays, major cost overruns, or DOE funding withdrawal that delay commercial production.

    sec.gov ↗

  • Inability to pass rising input costs through contracts or the market because customers push back or competitors absorb costs.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Solstice Advanced Materials

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed Solstice Advanced Materials’s thesis. Its break conditions are checked against every new filing as it lands.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. MIXED
    Reported results of operations (earnings release).

    Solstice Advanced Materials filed an SEC 8-K on 2026-11-04: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. MIXED
    Other material event.

    Solstice Advanced Materials filed an SEC 8-K on 2026-11-03: Other material event. It is a dated development that tests the current thesis.

  3. MIXED
    Entered a material definitive agreement.

    Solstice Advanced Materials filed an SEC 8-K on 2026-08-27: Entered a material definitive agreement. It is a dated development that tests the current thesis.

RISKS / FALSIFIERS

What could break the thesis

  • Regulators choose or accelerate policies that favor non‑fluorinated alternatives (making current chemistries less relevant).
  • Construction delays, major cost overruns, or DOE funding withdrawal that delay commercial production.
  • Inability to pass rising input costs through contracts or the market because customers push back or competitors absorb costs.
  • A multi‑year legal or environmental liability, regulatory fine, or settlement that requires large cash outflows.
  • Sustained lower margins and EPS from recurring higher input costs, structural pricing pressure, or permanent demand decline.

SOLS news

Loading headlines…

FINANCIAL STATEMENTS

SOLS income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

SOLS: quick answers

When does Solstice Advanced Materials (SOLS) report earnings next?
Solstice Advanced Materials's next results are projected for February 10, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 4, 2026. Earnings calendar
What is SOLS's short interest?
As of October 30, 2026, 4.7M SOLS shares were sold short, 2.97% of its shares outstanding, down 5.7% from the count before. At the stock's average daily volume that is 2.2 days to cover. FINRA publishes the count twice a month. SOLS short interest history
Have members of Congress traded SOLS?
Reports made public in the last 90 days disclose 3 trades in SOLS by 3 filers: 0 purchases and 3 sales. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed SOLS trade
Which well-known investors own SOLS?
1 of the 37 well-known funds tracked here reported SOLS shares in their latest 13F filing. By share of the fund's portfolio: Duquesne Family Office (Stanley Druckenmiller), 0.1%. Fund portfolios

SOLS in well-known investors’ portfolios

1 of 37 funds reported SOLS shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Stanley DruckenmillerDuquesne Family Office0.11%$5.5MNo changeQ2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.